Zum Hauptinhalt springen

Hepatitiden

12. Dezember 2022 | Hepatitiden

In a Real-Life Setting, Direct-Acting Antivirals to People Who Inject Drugs with Chronic Hepatitis C in Turkey.

In a Real-Life Setting, Direct-Acting Antivirals to People Who Inject Drugs with Chronic Hepatitis C in Turkey. Sarıgül Yıldırım F, Üser Ü, Sarı ND, Kurtaran B, Önlen Y, Şenateş E, Gündüz A, Zerdali E, Karsen H, Batırel A, Karaali R, Güner ...

12. Dezember 2022 | Hepatitiden

History of alcohol use does not predict HCV direct acting antiviral treatment outcomes.

History of alcohol use does not predict HCV direct acting antiviral treatment outcomes. Ia Okwor C, Petrosyan Y, Lee C, Cooper C. J Assoc Med Microbiol Infect Dis Can. 2022 Sep 27;7(3):233-241. doi: 10.3138/jammi-2021-0037. PMID: 363...

12. Dezember 2022 | Hepatitiden

Alcohol consumption upon direct-acting antiviral therapy for hepatitis C among persons with human immunodeficiency virus in the United States.

Alcohol consumption upon direct-acting antiviral therapy for hepatitis C among persons with human immunodeficiency virus in the United States. Chen PH, Yenokyan K, Fojo AT, Hutton HE, Lesko CR, McCaul ME, Yang C, Cachay ER, Crane HM, Jacobs...

12. Dezember 2022 | Hepatitiden

EASL recommendations on treatment of hepatitis C: Final update of the series

EASL recommendations on treatment of hepatitis C: Final update of the series Pawlotsky, Jean-MichelNegro, FrancescoAghemo, Alessio et al. Journal of Hepatology, Volume 73, Issue 5, 1170 - 1218 https://www.journal-of-hepatology.eu/article/...

11. Dezember 2022 | Hepatitiden

HCV microelimination in harm reduction centres has benefits beyond HCV cure but is hampered by high reinfection rates.

HCV microelimination in harm reduction centres has benefits beyond HCV cure but is hampered by high reinfection rates. Lens S, Miralpeix A, Gálvez M, Martró E, González N, Rodríguez-Tajes S, Mariño Z, Saludes V, Reyes-Urueña J, Majó X, Colo...

22. November 2022 | Hepatitiden

Development of Hepatocellular Carcinoma in Patients Aged 75-84 Years With Chronic Hepatitis C Treated With Direct-Acting Antivirals.

Development of Hepatocellular Carcinoma in Patients Aged 75-84 Years With Chronic Hepatitis C Treated With Direct-Acting Antivirals. Ogawa E, Nomura H, Nakamuta M, Furusyo N, Kajiwara E, Dohmen K, Kawano A, Ooho A, Azuma K, Takahashi K, Satoh T, ...

12. November 2022 | Hepatitiden

HIV? Hepatitis? Das CHECK ich!

HIV? Hepatitis? Das CHECK ich! Modellprojekt zu Beratungen und Tests für Menschen, die Drogen gebrauchen, durchgeführt in niedrigschwelligen Einrichtungen der Drogenhilfe. Abschlussbericht zu den Ergebnissen der Begleitevaluation Herausge...

Weitere Beiträge ansehen

Weitere
akutelle Informationen
zu den Themengebieten